Abstract:Background: Paracetamol (acetaminophen) is the most commonly prescribed analgesic for the treatment of acute pain. It may be administered orally or intravenously. The efficacy and safety of intravenous (IV) formulations of paracetamol, IV paracetamol and IV propacetamol, compared with placebo and other analgesics, is unclear. Objectives: To assess the efficacy and safety of IV formulations of paracetamol for treatment of postoperative pain in both adults and children. Search strategy: We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2010, Issue 2), MEDLINE (1950 to May 2010), EMBASE (1980 to 2010, Week 18), LILACS (1992 to May 2010) and reference lists of retrieved articles. Selection criteria: Randomized, double-blind, placebo- or active-controlled single dose clinical trials of IV propacetamol or IV paracetamol for acute postoperative pain in adults or children. Data collection and analysis: Two review authors independently assessed the risk of bias and extracted data. We contacted study authors for additional information. We collected adverse event information from the studies. Main results: Thirty-six studies (3896 participants) were included. Thirty-seven percent of participants receiving IV propacetamol/paracetamol experienced at least 50% pain relief over four hours compared with 16% of those receiving placebo (number needed to treat to benefit (NNT = 4.0; 95% confidence interval 3.5 to 4.8). The proportion of participants in IV propacetamol/paracetamol groups experiencing at least 50% pain relief diminished over six hours, as reflected in a higher NNT of 5.3 (4.2 to 6.7). Participants receiving IV propacetamol/paracetamol required 30% less opioid over four hours than those receiving placebo. However, this did not translate to a reduction in opioid-induced adverse events.Meta-analysis of efficacy comparisons between IV propacetamol/paracetamol and active comparators (opioids or nonsteroidal anti-inflammatories (NSAIDs)) were either not statistically significant, not clinically significant, or both.Adverse events occurred at similar rates with IV propacetamol or IV paracetamol and placebo. However, pain on infusion occurred more frequently in those receiving IV propacetamol versus placebo (23% versus 1%).Meta-analysis did not demonstrate statistically significant differences between IV propacetamol/paracetamol and active comparators for any adverse event except a reduction in the rate of hypotension versus NSAIDs and a reduction in the rate of gastrointestinal disorders versus opioids. Authors' conclusions: A single dose of both IV propacetamol and IV paracetamol provides around four hours of effective analgesia for about 37% of patients with acute postoperative pain. Both formulations are associated with few adverse events, although patients receiving IV propacetamol have a higher incidence of pain on infusion than both placebo and IV paracetamol.

Clinically significant hemodynamic alterations after propacetamol injection in the emergency department: prevalence and risk factors

Hemodynamic changes after propacetamol administration in patients with febrile UTI in the ED

Risk Factors for Intravenous Propacetamol-Induced Blood Pressure Drop in the Neurointensive Care Unit: A Retrospective Observational Study

Hemodynamic changes in patients with influenza A after propacetamol infusion in the emergency department

Effect of intravenous propacetamol on blood pressure in febrile critically ill patients

Propacetamol poses a potential harm of adverse hypotension in male and older patients

A Randomized Double-Blinded Dose-dependent Study of Metaraminol for Preventing Spinal-Induced Hypotension in Caesarean Delivery.

A narrative review of paracetamol-induced hypotension: Keeping the patient safe

Haemodynamic effects of intravenous acetaminophen in critically ill paediatric patients: a retrospective chart review

A study of the regional differences in propacetamol-related adverse events using VigiBase data of the World Health Organization

25 Enteral Acetaminophen Induced Hypotension: Getting It Right vs Being Right

The analgesic efficacy of an injectable prodrug of acetaminophen in children after orthopaedic surgery

The antipyretic efficacy and safety of propacetamol compared with dexibuprofen in febrile children: a multicenter, randomized, double-blind, comparative, phase 3 clinical trial

Single-dose intravenous paracetamol or propacetamol for prevention or treatment of postoperative pain: a systematic review and meta-analysis

Evaluation of the Regulatory Required Post-Authorization Safety Study for Propacetamol: Nested Case-Control and Case-Time-Control Studies

Paracetamol: not as safe as we thought? A systematic literature review of observational studies

Single dose intravenous propacetamol or intravenous paracetamol for postoperative pain

Intravenous paracetamol as an antipyretic and analgesic medication: the significance of drug metabolism

Hypersensitivity Reactions in Serious Adverse Events Reported for Paracetamol in the EudraVigilance Database, 2007–2018

The effect of combined ephedrine and lidocaine pretreatment on pain and hemodynamic changes due to propofol injection

Sodium-based Paracetamol: Impact on Blood Pressure, Cardiovascular Events, and All-Cause Mortality.